A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin 287; Drug: Insulin glargine Sponsor: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Endocrinology | Insulin | Overdose | Research | Study | Sugar